New cancer drug enters first human trials for aggressive tumors
Disease control
Recruiting now
This is the first human study of an experimental cancer drug called INBRX-109. Researchers are testing its safety and finding the right dose for people with advanced solid tumors that have spread or returned after previous treatments, including Ewing sarcoma. The study will also …
Phase: PHASE1 • Sponsor: Inhibrx Biosciences, Inc • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC